Paris-based Generare raises €20 million to generate novel molecular data for drug development from microbial genomes | EU-Startups

Generare, a Paris-based Biotech startup generating novel, high-quality molecular data for drug development by decoding microbial genomes, has raised €20 million in Series A funding to increase its drug discovery compound library, grow its team and scale its discovery platform. The round was co-led by Alven and Daphni with participation from all existing investors, including […] The post Paris-based Generare raises €20 million to generate novel molecular data for drug development from microbial genomes appeared first on EU-Startups.